Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DYN - Dyne Therapeutics, Inc.
54.3 M
LAST VALUE
-41.33%
2 YEAR CAGR
34.32%
5 YEAR CAGR
8.93%
10 YEAR CAGR